Standard
The epitranscriptome : Tools to study, manipulate, and exploit RNA modifications. / Nossent, Anne Yaël.
I:
Cardiovascular Research, Bind 115, Nr. 13, 01.11.2019, s. e133-e135.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
Nossent, AY 2019, '
The epitranscriptome: Tools to study, manipulate, and exploit RNA modifications',
Cardiovascular Research, bind 115, nr. 13, s. e133-e135.
https://doi.org/10.1093/cvr/cvz265
APA
Nossent, A. Y. (2019).
The epitranscriptome: Tools to study, manipulate, and exploit RNA modifications.
Cardiovascular Research,
115(13), e133-e135.
https://doi.org/10.1093/cvr/cvz265
Vancouver
Nossent AY.
The epitranscriptome: Tools to study, manipulate, and exploit RNA modifications.
Cardiovascular Research. 2019 nov. 1;115(13):e133-e135.
https://doi.org/10.1093/cvr/cvz265
Author
Nossent, Anne Yaël. / The epitranscriptome : Tools to study, manipulate, and exploit RNA modifications. I: Cardiovascular Research. 2019 ; Bind 115, Nr. 13. s. e133-e135.
Bibtex
@article{2999f564dd5841778e4382be6a8d904a,
title = "The epitranscriptome: Tools to study, manipulate, and exploit RNA modifications",
author = "Nossent, {Anne Ya{\"e}l}",
note = "Funding Information: Dr Nossent is funded by a Lise Meitner Grant from the Austrian Science Fund FWF (M2578-B30). Funding Information: Biography: Anne Ya{\"e}l Nossent after completing her postdoc at the University of Copenhagen and the University of Southern Denmark, Dr Nossent initiated an independent research line on the role of microRNAs in neovascularisation at the Leiden University Medical Center in Netherlands. She was awarded a personal Veni grant by Netherlands Organization for Scientific Research to support this line of research. In her Veni project, she demonstrated a role for the 14q32 miRNAs in post-ischemic neovascularization. Dr Nossent and colleagues also demonstrated positive effects of 14q32 miRNA inhibition on atherosclerosis and restenosis. Besides 54 miRNAs however, the 14q32 locus also encodes 3 lncRNA and 41 snoRNAs. Dr Nossent was recently awarded grants by Netherlands Heart Foundation and the Rembrandt Institute for Cardiovascular Sciences to support further research on the role of these lncRNAs and snoRNAs in cardiovascular disease. In September 2017, Dr Nossent moved to Vienna, Austria, where she continues her research on noncoding RNAs, supported by a Lise Meitner Grant from the Austrian Science Fund FWF. She now holds a dual affiliation with both the Medical University of Vienna and the Leiden University Medical Center.",
year = "2019",
month = nov,
day = "1",
doi = "10.1093/cvr/cvz265",
language = "English",
volume = "115",
pages = "e133--e135",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "13",
}
RIS
TY - JOUR
T1 - The epitranscriptome
T2 - Tools to study, manipulate, and exploit RNA modifications
AU - Nossent, Anne Yaël
N1 - Funding Information:
Dr Nossent is funded by a Lise Meitner Grant from the Austrian Science Fund FWF (M2578-B30).
Funding Information:
Biography: Anne Yaël Nossent after completing her postdoc at the University of Copenhagen and the University of Southern Denmark, Dr Nossent initiated an independent research line on the role of microRNAs in neovascularisation at the Leiden University Medical Center in Netherlands. She was awarded a personal Veni grant by Netherlands Organization for Scientific Research to support this line of research. In her Veni project, she demonstrated a role for the 14q32 miRNAs in post-ischemic neovascularization. Dr Nossent and colleagues also demonstrated positive effects of 14q32 miRNA inhibition on atherosclerosis and restenosis. Besides 54 miRNAs however, the 14q32 locus also encodes 3 lncRNA and 41 snoRNAs. Dr Nossent was recently awarded grants by Netherlands Heart Foundation and the Rembrandt Institute for Cardiovascular Sciences to support further research on the role of these lncRNAs and snoRNAs in cardiovascular disease. In September 2017, Dr Nossent moved to Vienna, Austria, where she continues her research on noncoding RNAs, supported by a Lise Meitner Grant from the Austrian Science Fund FWF. She now holds a dual affiliation with both the Medical University of Vienna and the Leiden University Medical Center.
PY - 2019/11/1
Y1 - 2019/11/1
UR - http://www.scopus.com/inward/record.url?scp=85073667637&partnerID=8YFLogxK
U2 - 10.1093/cvr/cvz265
DO - 10.1093/cvr/cvz265
M3 - Comment/debate
C2 - 31605610
AN - SCOPUS:85073667637
VL - 115
SP - e133-e135
JO - Cardiovascular Research
JF - Cardiovascular Research
SN - 0008-6363
IS - 13
ER -
